Dr. Jingfeng Li earned his Ph.D. in Cell Biology and Tumor Biology from the Karolinska Institute, Sweden. He previously held an assistant professor position at the Division of Medical Oncology, The Ohio State University, USA. Currently, he serves as a professor at the College of Pharmacology, Yantai University in China. Dr. Li's research focuses on elucidating the functional role of HPV in the development of specific cancers. Additionally, he is involved in engineering Herpes Simplex Virus (HSV) for oncolytic virus and gene therapy vector applications. His work also extends to the development of novel genome editing tools for modern gene therapy. Dr. Li's diverse expertise contributes to advancing our understanding of cancer biology and developing innovative approaches for therapeutic interventions.
- Papers in database
- 1
- Years active
- 2024
- Total publications
- 76
- Total citations
- 2,597
- h-index
- 23
Research Areas
- RNA modifications and cancer
- Chromosomal and Genetic Variations
- CRISPR and Genetic Engineering
- Pancreatic and Hepatic Oncology Research
- Ubiquitin and proteasome pathways
Papers (1)
- 2024Osteoporotic osseointegration: therapeutic hallmarks and engineering strategies.10.7150/thno.96516